Literature DB >> 1767538

Asymptomatic primary hyperparathyroidism.

B J Harrison1, M H Wheeler.   

Abstract

The criteria used in selecting patients with asymptomatic hyperparathyroidism (HPT) for surgery remain controversial. Do patients with asymptomatic HPT have less severe disease (smaller glands and less derangement of biochemistry) than those with symptoms? We studied a consecutive series of 111 patients with HPT surgically treated and compared the symptomatic patients (n = 83) and asymptomatic patients (n = 28). There were no significant differences between the two patient groups with respect to age, serum calcium, PTH (intact 1-84), and excised gland weights (adenomas). Hypercalcemia was cured in all patients. The natural history of mild or asymptomatic HPT is unknown, but we summarize the current knowledge relating to mortality, cardiovascular/renal disease, psychiatric and neuromuscular disorders, and bone disease. Symptoms of HPT do not correlate with the degree of biochemical and pathological derangement. Furthermore clinical assessment does not predict severity of disease and should not be the sole basis of selection for surgery. The results of surgery for primary HPT permit us to advocate a liberal approach to the selection of asymptomatic patients for operation.

Entities:  

Mesh:

Year:  1991        PMID: 1767538     DOI: 10.1007/bf01665306

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  44 in total

1.  Primary hyperparathyroidism: clinical and biochemical features.

Authors:  L E Mallette; J P Bilezikian; D A Heath; G D Aurbach
Journal:  Medicine (Baltimore)       Date:  1974-03       Impact factor: 1.889

2.  Depression.

Authors:  H M van Praag
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

3.  Effect of parathyroidectomy on left-ventricular function in haemodialysis patients.

Authors:  T Drüeke; M Fauchet; J Fleury; P Lesourd; Y Toure; C Le Pailleur; P de Vernejoul; J Crosnier
Journal:  Lancet       Date:  1980-01-19       Impact factor: 79.321

4.  Asymptomatic hyperparathyroidism: an assessment of operative intervention.

Authors:  J J Graham; P E Harding; L L Hoare; D W Thomas; P H Wise
Journal:  Br J Surg       Date:  1980-02       Impact factor: 6.939

5.  Back pain and vertebral crush fractures: an unemphasized mode of presentation for primary hyperparathyroidism.

Authors:  R T Dauphine; B L Riggs; D A Scholz
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

6.  Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay.

Authors:  R C Brown; J P Aston; I Weeks; J S Woodhead
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

7.  Causes of death in patients previously operated on for primary hyperparathyroidism.

Authors:  H Ronni-Sivula
Journal:  Ann Chir Gynaecol       Date:  1985

8.  Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979.

Authors:  M Palmér; H O Adami; R Bergström; G Akerström; S Ljunghall
Journal:  Surgery       Date:  1987-07       Impact factor: 3.982

9.  Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up.

Authors:  M Palmer; H O Adami; R Bergström; S Jakobsson; G Akerström; S Ljunghall
Journal:  Lancet       Date:  1987-01-10       Impact factor: 79.321

10.  Conservative management of primary hyperparathyroidism.

Authors:  P H Adams
Journal:  J R Coll Physicians Lond       Date:  1982-07
View more
  10 in total

Review 1.  Primary hyperparathyroidism: a surgical perspective.

Authors:  M H Wheeler
Journal:  Ann R Coll Surg Engl       Date:  1998-09       Impact factor: 1.891

2.  Comparison of 'intraoperative' parathormone measurement with frozen section during parathyroid surgery.

Authors:  M H Wheeler
Journal:  Ann R Coll Surg Engl       Date:  1993-09       Impact factor: 1.891

3.  Pharmacodynamic behaviour of vecuronium in primary hyperparathyroidism.

Authors:  E J Roland; J M Wierda; B G Eurin; E Roupie
Journal:  Can J Anaesth       Date:  1994-08       Impact factor: 5.063

Review 4.  Primary hyperparathyroidism, cognition, and health-related quality of life.

Authors:  Laura H Coker; Kashemi Rorie; Larry Cantley; Kimberly Kirkland; David Stump; Nicole Burbank; Terry Tembreull; Jeff Williamson; Nancy Perrier
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

Review 5.  Asymptomatic primary hyperparathyroidism.

Authors:  J C Birkenhäger; R Bouillon
Journal:  Postgrad Med J       Date:  1996-06       Impact factor: 2.401

6.  Brown jaw tumors: today's unusual presentation of primary hyperparathyroidism.

Authors:  S Corbetta; D Rossi; O D'Orto; L Vicentini; P Beck-Peccoz; A Spada
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

7.  Timing of symptom improvement after parathyroidectomy for primary hyperparathyroidism.

Authors:  Sara E Murray; Priya R Pathak; David S Pontes; David F Schneider; Sarah C Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  Surgery       Date:  2013-10-04       Impact factor: 3.982

8.  Limited role for intraoperative intact PTH measurement in parathyroid surgery.

Authors:  P Tan; S H Leveson; H Wilkinson
Journal:  Ann R Coll Surg Engl       Date:  1995-01       Impact factor: 1.891

9.  Use of the gamma probe to identify multigland disease in primary hyperparathyroidism.

Authors:  Kirby Tobin; Rachel R Ayers; Mohammad Rajaei; Rebecca S Sippel; Courtney J Balentine; Dawn Elfenbein; Herb Chen; David F Schneider
Journal:  Int J Endocr Oncol       Date:  2016-02

10.  [Assessment of the quality of life of patients after parathyroidectomy from standard and small access].

Authors:  A V Ogorodnikov; S S Kharnas
Journal:  Probl Endokrinol (Mosk)       Date:  2021-02-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.